Infinium ImmunoArray-24

Infinium ImmunoArray-24 (24-sample)

The Infinium ImmunoArray-24 v2.0 BeadChip is the next-generation genotyping array for detecting genetic variation in the human immune system. This updated array is based on the HumanImmuno v1.0 BeadChip, which has been cited in over 120 publications. Like its predecessor, it was designed for deep replication of genome-wide association studies (GWAS) and fine mapping of susceptibility loci in multiple immune-mediated disorders.

Please rotate your device for details

Specifications*
Number of Fixed Markers 253,702
Available Custom Markers, max. 390,000
Number of Samples 24
DNA Requirement 200 ng
Assay Infinium HTS
Major Autoimmune and Inflammatory diseases represented
  • Allergy
  • Alopecia Arreata
  • Ankylosing Spondylitis
  • Asthma
  • Celiac Disease
  • Hodgkin’s Lymphoma
  • Inflammatory Bowel Disease
  • Multiple Sclerosis
  • Psoriasis
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Systemic Sclerosis
  • Type 1 Diabetes
  • Vitiligo

*Please see the Data Sheet for additional product specifications

Ordering Information

  • Infinium ImmunoArray-24 v2.0 BeadChip Kits: WG-357-1001 (48 samples), WG-357-1002 (288 samples), WG-357-1003 (1152 samples)
  • Infinium ImmunoArray-24+ v2.0 BeadChip Kits (Enabled for additional custom content): WG-357-1011 (48 samples), WG-357-1012 (288 samples), WG-357-1013 (1152 samples)
  • Infinium ImmunoArray Product Page

Support Links

Order Now Support
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.